$JAGX News Article - Orphan Drug Designation Application Submitted by Jaguar Health Subsidiary for Crofelemer for Short Bowel Syndrome with Intestinal Failure Accepted for Review by European Medicines Agency
https://marketwirenews.com/news-releases/orph...80203.html